Bacteremia secondary to pneumonia caused by carbapenem-resistant Klebsiella pneumoniae carries a high mortality rate, but combination antimicrobial regimens involving polymyxins, tigecycline, or carbapenems improve survival compared with monotherapy, according to the findings of an observational treatment study conducted at two medical centers.